Optas, LLC Abb Vie Inc. Transaction History

Optas, LLC

$429 Million
Q3 2024

A detailed history of Optas, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Optas, LLC holds 4,515 shares of ABBV stock, worth $765,879. This represents 0.21% of its overall portfolio holdings.

Number of Shares

4,515

Previous 3,905 15.62%

Holding current value

$765,879

Previous $669,000 33.18%

% of portfolio

0.21%

Previous 0.17%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$163.84 - $199.33 $99,942 - $121,591	610 Added 15.62%	4,515 $891,000
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $49,997 - $58,385	323 Added 9.02%	3,905 $669,000
Q1 2024 Apr 17, 2024	BUY	$159.82 - $182.1 $56,736 - $64,645	355 Added 11.0%	3,582 $652,000
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $229,654 - $258,644	-1,669 Reduced 34.09%	3,227 $500,000
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $75,211 - $87,067	563 Added 12.99%	4,896 $729,000
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $58,966 - $73,380	-445 Reduced 9.31%	4,333 $583,000
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $35,718 - $41,135	247 Added 5.45%	4,778 $761,000
Q4 2022 Jan 27, 2023	BUY	$138.31 - $165.87 $5,670 - $6,800	41 Added 0.91%	4,531 $732,000
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $22,547 - $25,860	168 Added 3.89%	4,490 $603,000
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $214,962 - $273,287	1,562 Added 56.59%	4,322 $661,000
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $10,690 - $13,263	81 Added 3.02%	2,760 $447,000
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $11,495 - $14,544	107 Added 4.16%	2,679 $363,000
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $4,575 - $5,193	-43 Reduced 1.64%	2,572 $278,000
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $4,524 - $5,040	43 Added 1.67%	2,615 $294,000
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $190,761 - $257,547	-2,370 Reduced 47.96%	2,572 $276,000
Q3 2020 Oct 23, 2020	BUY	$85.91 - $100.83 $243,125 - $285,348	2,830 Added 134.0%	4,942 $431,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $154,957 - $207,356	2,112 New	2,112 $208,000

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.

Account